Department Of Microbiology 1
1. A SPECTROPHOTOMETRIC DETERMINATION AND THE QUANTUM CHEMICAL INVESTIGATION OF Pd(II)-3-HYDROXY-2-(4-METHOXYPHENYL)-4-OXO-4H-1-BENZOPYRAN COMPLEX
2. Integrating Molecular and Ecological Insights for better understanding of Bioremediation Potential of Indigenous Fungal Isolates from the Marble Wastewater
3. Evaluation of extracellular electron transfer in Pseudomonas aeruginosa by co-expression of intermediate genes in NAD synthetase production pathway
4. Influence of enhanced electrogenicity on anodic biofilm and bioelectricity production by a novel microbial consortium
5. Biochemical and electrochemical characterization of biofilms formed on everolimus-eluting coronary stents
6. Harnessing Microalgae and Cyanobacteria for Sustainable Pesticide Biodegradation: Advances, Challenges, and Ecological Benefits
7. Experimental and theoretical investigation into the design of nickel(II), copper(II), and zinc(II) complexes substituted with pyrazole ligand
8. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
9. Editorial: Rising stars in biofilms 2022
10. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
11. Editorial: Salt Tolerant Rhizobacteria: For Better Productivity and Remediation of Saline Soils
12. SPECTROPHOTOMETRIC, QUANTUM CHEMICAL AND MOLECULAR DOCKING INVESTIGATIONS OF 4H-1-BENZOPYRAN-DERIVED Pd(II) COMPLEXES
13. THE COVID-19 VACCINATION ACCEPTANCE/HESITANCY RATE AND ITS DETERMINANTS AMONG HEALTHCARE WORKERS OF 91 COUNTRIES: A MULTICENTER CROSS-SECTIONAL STUDY
14. Phylogenetic and phylodynamic analysis of respiratory syncytial virus strains circulating in children less than five years of age in Karachi-Pakistan
15. Evaluating student understanding of core pharmacokinetic concepts
16. In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation
17. Prognostic Biomarkers for Predicting Decompensation in Alcoholic and Nonalcoholic Patients With Compensated Cirrhosis: An Umbrella Review
18. Prognostic biomarkers for predicting decompensation in alcoholic and non-alcoholic patients with compensated cirrhosis: a systematic review and meta-analysis
19. In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers
20. Knowledge and perceptions of infectious disease physicians about epidemiology, causes, diagnosis, treatment and prevention of Q fever in the Republic of Kazakhstan: results of online survey
21. Fecal elastase test in diagnosing exocrine pancreatic insufficiency: The web of science and scopus bibliometric analysis (1984–2024)
22. Fermented camel milk as a probiotics source for poultry farming
23. Probiotics effects on the growth performance and meat quality of broiler chickens
24. Prevalence of nasopharyngeal Streptococcus Pneumoniae in infants: A systematic review and meta-analysis of cohort studies and randomized controlled trials
25. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
26. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
27. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
28. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
29. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
30. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
31. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
32. Investigation of the Antibiotic Resistance and Biofilm-Forming Ability of Staphylococcus species from Bovine Mastitis cases in the Almaty Region, Kazakhstan
33. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
34. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
35. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
36. Chemical analysis of the state of Ukrainian soils in the combat zone
37. Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
38. Study of the Formation and Maintenance of Immunological Memory Cells in Response to Immunization for Myxomatosis and Viral Hemorrhagic Disease in Rabbits
39. Surveillance of Salmonella and antimicrobial resistance in industrial poultry enterprises: biofilm-forming strains and critical control points
40. Characterisation of the Endophytic and Rhizospheric Bacillus licheniformis Strains Isolated from Sweet Potato with Plant Growth-Promoting and Yield Enhancing Potential
41. Exploring the frontiers of penicillin pharmaceuticals: a comprehensive review of advancements and innovations
42. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
43. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
44. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
45. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
46. Unmet needs in hereditary angioedema: an international survey of physicians
47. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
48. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
49. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
50. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
1 2 3 6